Dynamic pressure-flow relationship of the cerebral circulation during acute increase in arterial pressure.
The physiological mechanism(s) for the regulation of the dynamic pressure-flow relationship of the cerebral circulation are not well understood. We studied the effects of acute cerebral vasoconstriction on the transfer function between spontaneous changes in blood pressure (BP) and cerebral blood flow velocity (CBFV) in 13 healthy subjects (30 +/- 7 years). CBFV was measured in the middle cerebral artery using transcranial Doppler. BP was increased stepwise with phenylephrine infusion at 0.5, 1.0 and 2.0 microg kg(-1) min(-1). Phenylephrine increased BP by 11, 23 and 37% from baseline, while CBFV increased (11%) only with the highest increase in BP. Cerebrovascular resistance index (BP/CBFV) increased progressively by 6, 17 and 23%, demonstrating effective steady-state autoregulation. Transfer function gain at the low frequencies (LF, 0.07-0.20 Hz) was reduced by 15, 14 and 14%, while the phase was reduced by 10, 17 and 31%. A similar trend of changes was observed at the high frequencies (HF, 0.20-0.35 Hz), but gain and phase remained unchanged at the very low frequencies (VLF, 0.02-0.07 Hz). Windkessel model simulation suggests that increases in steady-state cerebrovascular resistance and/or decreases in vascular compliance during cerebral vasoconstriction contribute to the changes in gain and phase. These findings suggest that changes in steady-state cerebrovascular resistance and/or vascular compliance modulate the dynamic pressure-flow relationship at the low and high frequencies, while dynamic autoregulation is likely to be dominant at the very low frequencies. Thus, oscillations in CBFV are modulated not only by dynamic autoregulation, but also by changes in steady-state cerebrovascular resistance and/or vascular compliance.
Institute for Exercise and Environmental Medicine, Presbyterian Hospital of Dallas, TX 75231, USA. rongzhang@texashealth.org
Rong
R
Zhang
Khosrow
K
Behbehani
Benjamin D
BD
Levine
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003187:Compliance; D004305:Dose-Response Relationship, Drug; D005260:Female; D005385:Fingers / Q000098:blood supply*; D006706:Homeostasis; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D020768:Middle Cerebral Artery / Q000000981:diagnostic imaging / Q000187:drug effects / Q000502:physiology*; D008955:Models, Cardiovascular; D010656:Phenylephrine / Q000008:administration & dosage; D017156:Photoplethysmography; D017534:Radial Artery / Q000187:drug effects / Q000502:physiology*; D012016:Reference Values; D012039:Regional Blood Flow; D012815:Signal Processing, Computer-Assisted; D013997:Time Factors; D017585:Ultrasonography, Doppler, Transcranial; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000008:administration & dosage; D055815:Young Adult
D014662:Vasoconstrictor Agents; D010656:Phenylephrine